Article

AJMC® in the Press, January 15, 2021

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A piece by Becker’s Hospital Review spotlighted a commentary published in the January 2021 Health Information Technology special issue of The American Journal of Managed Care® (AJMC®). The commentary, “Addressing Evolving Patient Concerns Around Telehealth in the COVID-19 Era,” highlighted that with the rapid shift to telehealth during the coronavirus disease 2019 pandemic, clinicians, health care organizations, and policy makers must consider and address patients’ evolving needs, concerns, and expectations.

An article published on AJMC.com, the website of AJMC®, was spotlighted by Healthline. The article, “Abbott's Freestyle Libre CGM Gains Medicare Coverage,” reported on a factory-calibrated continuous glucose monitoring system touted as less expensive, with a spokeswoman saying it will not require bundling with a meter, which is required for a competitor.

In a press release issued by KMK Consulting and published on EIN Presswire, a report published in a supplement to AJMC®, “Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis: A Managed Care Perspective,” was referenced. The report, titled, “Economic Burden of Multiple Sclerosis and the Role of Managed Care Organizations in Multiple Sclerosis Management,” noted that treatment for multiple sclerosis should be individualized and shared decision-making between patients and health care providers must be preserved.

Related Videos
Benjamin Scirica, MD, MPH, associate professor of medicine at Harvard Medical School and director of quality initiatives at Brigham and Women’s Hospital’s Cardiovascular Division
Laurence Sperling, MD
Brooke Kempf
Tiara Green MSEd
Tiara Green MSEd
Tiara Green, MSEd
Michael Morse, MD, Duke Cancer Center
Screenshot of Ryan Nix, PharmD, during a video interview
Ryan Stice, PharmD
Leslie Fish, PharmD.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo